104 related articles for article (PubMed ID: 28009152)
1. Lung tumors, COPD and immune response: is epigenetics the bottom line?
Balestro E; Baraldo S; Piloni D; Stella GM
Minerva Med; 2016 Dec; 107(6 Suppl 1):1-8. PubMed ID: 28009152
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation profiling of non-small cell lung cancer reveals a COPD-driven immune-related signature.
Wauters E; Janssens W; Vansteenkiste J; Decaluwé H; Heulens N; Thienpont B; Zhao H; Smeets D; Sagaert X; Coolen J; Decramer M; Liston A; De Leyn P; Moisse M; Lambrechts D
Thorax; 2015 Dec; 70(12):1113-22. PubMed ID: 26349763
[TBL] [Abstract][Full Text] [Related]
3. Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations.
Lim JU; Yeo CD; Rhee CK; Kim YH; Park CK; Kim JS; Kim JW; Lee SH; Kim SJ; Yoon HK; Kim TJ; Lee KY
PLoS One; 2015; 10(11):e0142306. PubMed ID: 26555338
[TBL] [Abstract][Full Text] [Related]
4. Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer.
Schmid S; Kübler M; Korcan Ayata C; Lazar Z; Haager B; Hoßfeld M; Meyer A; Cicko S; Elze M; Wiesemann S; Zissel G; Passlick B; Idzko M
Lung Cancer; 2015 Dec; 90(3):516-21. PubMed ID: 26505137
[TBL] [Abstract][Full Text] [Related]
5. Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer.
Mark NM; Kargl J; Busch SE; Yang GHY; Metz HE; Zhang H; Hubbard JJ; Pipavath SNJ; Madtes DK; Houghton AM
Am J Respir Crit Care Med; 2018 Feb; 197(3):325-336. PubMed ID: 28934595
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling.
Suzuki M; Wada H; Yoshino M; Tian L; Shigematsu H; Suzuki H; Alaa M; Tamura H; Fujiwara T; Nagato K; Motohashi S; Moriya Y; Hoshino H; Yoshida S; Shibuya K; Hiroshima K; Nakatani Y; Yoshino I
Ann Surg Oncol; 2010 Mar; 17(3):878-88. PubMed ID: 19841986
[TBL] [Abstract][Full Text] [Related]
7. Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): moderate/severe versus mild stage of COPD.
Marc MM; Korosec P; Kern I; Sok M; Ihan A; Kosnik M
Scand J Immunol; 2007 Dec; 66(6):694-702. PubMed ID: 17949407
[TBL] [Abstract][Full Text] [Related]
8. State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer.
Brody JS; Spira A
Proc Am Thorac Soc; 2006 Aug; 3(6):535-7. PubMed ID: 16921139
[TBL] [Abstract][Full Text] [Related]
9. Association between Th17-related cytokines and risk of non-small cell lung cancer among patients with or without chronic obstructive pulmonary disease.
Liao C; Yu ZB; Meng G; Wang L; Liu QY; Chen LT; Feng SS; Tu HB; Li YF; Bai L
Cancer; 2015 Sep; 121 Suppl 17():3122-9. PubMed ID: 26331819
[TBL] [Abstract][Full Text] [Related]
10. Effect of COPD on Inflammation, Lymphoid Functions and Progression-Free Survival during First-Line Chemotherapy in Advanced Non-small Cell Lung Cancer.
Szentkereszty M; Komlósi ZI; Szűcs G; Barna G; Tamási L; Losonczy G; Gálffy G
Pathol Oncol Res; 2020 Apr; 26(2):1117-1128. PubMed ID: 31090020
[TBL] [Abstract][Full Text] [Related]
11. Immunology, genetics and microbiota in the COPD pathophysiology: potential scope for patient stratification.
Malhotra R; Olsson H
Expert Rev Respir Med; 2015 Apr; 9(2):153-9. PubMed ID: 25586213
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation profiling of non-small cell lung cancer reveals a COPD-driven immune-related signature.
Sethi T
Thorax; 2015 Dec; 70(12):1110-1. PubMed ID: 26567185
[No Abstract] [Full Text] [Related]
13. Association of genetic dependences between lung cancer and chronic obstructive pulmonary disease.
Grudny J; Kołakowski J; Kruszewski M; Szopiński J; Sliwiński P; Wiatr E; Winek J; Załęska J; Zych J; Roszkowski-Śliż K
Pneumonol Alergol Pol; 2013; 81(4):308-18. PubMed ID: 23744166
[TBL] [Abstract][Full Text] [Related]
14. [Lung cancer and its epigenetics association with chronic obstructive pulmonary disease].
Xu PW; Jin YT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Feb; 30(1):70-3. PubMed ID: 23450484
[TBL] [Abstract][Full Text] [Related]
15. Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients.
Guadagni F; Ferroni P; Basili S; Facciolo F; Carlini S; Crecco M; Martini F; Spila A; D'Alessandro R; Aloe S; Cerasoli V; Del Monte G; Mariotti S; Mineo TC; Roselli M
Lung Cancer; 2004 Jun; 44(3):303-10. PubMed ID: 15140543
[TBL] [Abstract][Full Text] [Related]
16. Genomic mechanisms of transformation from chronic obstructive pulmonary disease to lung cancer.
Wang DC; Shi L; Zhu Z; Gao D; Zhang Y
Semin Cancer Biol; 2017 Feb; 42():52-59. PubMed ID: 27840275
[TBL] [Abstract][Full Text] [Related]
17. Chronic obstructive pulmonary disease and lung cancer: new molecular insights.
Adcock IM; Caramori G; Barnes PJ
Respiration; 2011; 81(4):265-84. PubMed ID: 21430413
[TBL] [Abstract][Full Text] [Related]
18. Involvement of inflammatory cytokines and epigenetic modification of the mtTFA complex in T-helper cells of patients' suffering from non-small cell lung cancer and chronic obstructive pulmonary disease.
Shanmugam G; Sunny JS; Rakshit S; George M; Leela KV; Sarkar K
Mol Immunol; 2022 Nov; 151():70-83. PubMed ID: 36099831
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer.
Tessema M; Yingling CM; Picchi MA; Wu G; Liu Y; Weissfeld JL; Siegfried JM; Tesfaigzi Y; Belinsky SA
J Thorac Oncol; 2015 Aug; 10(8):1181-8. PubMed ID: 26200272
[TBL] [Abstract][Full Text] [Related]
20. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer.
Lee SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Han SK; Kim YW
J Thorac Oncol; 2014 Jun; 9(6):812-7. PubMed ID: 24807154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
